139 related articles for article (PubMed ID: 27847096)
41. Genetic screening of patients with medullary thyroid cancer in a referral center in Greece during the past two decades.
Sarika HL; Papathoma A; Garofalaki M; Saltiki K; Pappa T; Pazaitou-Panayiotou K; Anastasiou E; Alevizaki M
Eur J Endocrinol; 2015 Apr; 172(4):501-9. PubMed ID: 25624014
[TBL] [Abstract][Full Text] [Related]
42. Analysis of RET polymorphisms and haplotypes in the context of sporadic medullary thyroid carcinoma.
Fernández RM; Peciña A; Antiñolo G; Navarro E; Borrego S
Thyroid; 2006 Apr; 16(4):411-7. PubMed ID: 16646689
[TBL] [Abstract][Full Text] [Related]
43. RET Gene Analysis in Patients with Medullary Thyroid Carcinoma.
Kheiroddin P; Rasihashemi SZ; Estiar MA; Mahmudian B; Halimi M; Mousavi F; Nemati M; Sakhinia E
Clin Lab; 2016; 62(5):871-6. PubMed ID: 27349013
[TBL] [Abstract][Full Text] [Related]
44. RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency.
Ramone T; Mulè C; Ciampi R; Bottici V; Cappagli V; Prete A; Matrone A; Piaggi P; Torregrossa L; Basolo F; Elisei R; Romei C
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33383911
[TBL] [Abstract][Full Text] [Related]
45. A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.
Romei C; Ciampi R; Elisei R
Nat Rev Endocrinol; 2016 Apr; 12(4):192-202. PubMed ID: 26868437
[TBL] [Abstract][Full Text] [Related]
46. Thyroid cancer and co-occurring RET mutations in Hirschsprung disease.
Virtanen VB; Pukkala E; Kivisaari R; Salo PP; Koivusalo A; Arola J; Miettinen PJ; Rintala RJ; Perola M; Pakarinen MP
Endocr Relat Cancer; 2013 Aug; 20(4):595-602. PubMed ID: 23744765
[TBL] [Abstract][Full Text] [Related]
47. Clinical significance of RET and RAS mutations in sporadic medullary thyroid carcinoma: a meta-analysis.
Vuong HG; Odate T; Ngo HTT; Pham TQ; Tran TTK; Mochizuki K; Nakazawa T; Katoh R; Kondo T
Endocr Relat Cancer; 2018 Jun; 25(6):633-641. PubMed ID: 29615431
[TBL] [Abstract][Full Text] [Related]
48. Germline RET mutations in exons 10 and 11: an Iranian survey of 57 medullary thyroid carcinoma cases.
Hedayati M; Nabipour I; Rezaei-Ghaleh N; Azizi F
Med J Malaysia; 2006 Dec; 61(5):564-9. PubMed ID: 17623957
[TBL] [Abstract][Full Text] [Related]
49. Long-Term Control of Hypercortisolism by Vandetanib in a Case of Medullary Thyroid Carcinoma with a Somatic RET Mutation.
Paepegaey AC; Cochand-Priollet B; Louiset E; Sarfati PO; Alifano M; Burnichon N; Bienvenu-Perrard M; Lahlou N; Bricaire L; Groussin L
Thyroid; 2017 Apr; 27(4):587-590. PubMed ID: 28068878
[TBL] [Abstract][Full Text] [Related]
50. RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series.
Fugazzola L; Muzza M; Mian C; Cordella D; Barollo S; Alberti L; Cirello V; Dazzi D; Girelli ME; Opocher G; Beck-Peccoz P; Persani L
Clin Endocrinol (Oxf); 2008 Sep; 69(3):418-25. PubMed ID: 18284634
[TBL] [Abstract][Full Text] [Related]
51. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
[TBL] [Abstract][Full Text] [Related]
52. Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma.
Cebrian A; Lesueur F; Martin S; Leyland J; Ahmed S; Luccarini C; Smith PL; Luben R; Whittaker J; Pharoah PD; Dunning AM; Ponder BA
J Clin Endocrinol Metab; 2005 Nov; 90(11):6268-74. PubMed ID: 16091499
[TBL] [Abstract][Full Text] [Related]
53. Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease.
Jayakody S; Reagh J; Bullock M; Aniss A; Clifton-Bligh R; Learoyd D; Robinson B; Delbridge L; Sidhu S; Gill AJ; Sywak M
World J Surg; 2018 May; 42(5):1432-1439. PubMed ID: 29484475
[TBL] [Abstract][Full Text] [Related]
54. Surgical Treatment of Medullary Thyroid Cancer.
Machens A; Dralle H
Recent Results Cancer Res; 2015; 204():187-205. PubMed ID: 26494390
[TBL] [Abstract][Full Text] [Related]
55. Long-term outcome of "prophylactic therapy" for familial medullary thyroid cancer.
Schellhaas E; König C; Frank-Raue K; Buhr HJ; Hotz HG
Surgery; 2009 Nov; 146(5):906-12. PubMed ID: 19744457
[TBL] [Abstract][Full Text] [Related]
56. mTOR activation in medullary thyroid carcinoma with RAS mutation.
Lyra J; Vinagre J; Batista R; Pinto V; Prazeres H; Rodrigues F; Eloy C; Sobrinho-Simões M; Soares P
Eur J Endocrinol; 2014 Nov; 171(5):633-40. PubMed ID: 25163725
[TBL] [Abstract][Full Text] [Related]
57. Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma?
Baumgartner-Parzer SM; Lang R; Wagner L; Heinze G; Niederle B; Kaserer K; Waldhäusl W; Vierhapper H
J Clin Endocrinol Metab; 2005 Nov; 90(11):6232-6. PubMed ID: 16118333
[TBL] [Abstract][Full Text] [Related]
58. The clinical spectrum of RET proto-oncogene mutations in codon 790.
Bihan H; Murat A; Fysekidis M; Al-Salameh A; Schwartz C; Baudin E; Thieblot P; Borson-Chazot F; Guillausseau PJ; Cardot-Bauters C; Raingeard I; Requeda E; Sadoul JL; Reznik Y;
Eur J Endocrinol; 2013 Sep; 169(3):271-6. PubMed ID: 23756355
[TBL] [Abstract][Full Text] [Related]
59. Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study.
Xu B; Viswanathan K; Ahadi MS; Ahmadi S; Alzumaili B; Bani MA; Baudin E; Behrman DB; Capelletti M; Chau NG; Chiarucci F; Chou A; Clifton-Bligh R; Coluccelli S; de Biase D; De Leo A; Dogan S; Fagin JA; Fuchs TL; Glover AR; Hadoux J; Lacroix L; Lamartina L; Lubin DJ; Luxford C; Magliocca K; Maloberti T; Mohanty AS; Najdawi F; Nigam A; Papachristos AJ; Repaci A; Robinson B; Scoazec JY; Shi Q; Sidhu S; Solaroli E; Sywak M; Tuttle RM; Untch B; Barletta JA; Al Ghuzlan A; Gill AJ; Ghossein R; Tallini G; Ganly I
Thyroid; 2024 Feb; 34(2):167-176. PubMed ID: 37842841
[No Abstract] [Full Text] [Related]
60. Higher
Mulè C; Ciampi R; Ramone T; Prete A; Matrone A; Cappagli V; Torregrossa L; Basolo F; Elisei R; Romei C
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
